PR Newswire
BOSTON, Aug. 10, 2022
Financial release accessible online
BOSTON, Aug. 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2023, which ended July 2, 2022, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EDT on August 10, 2022. The conference call and webcast can be accessed with the following information:
In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 1Q FY23 Earnings Release:
https://haemonetics.gcs-web.com/static-files/28d85dc8-1d09-4355-937b-0cc17f6d51a5
Direct link to 1Q FY23 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/4abb751e-3eb6-41a8-a06b-b3c48ba9d5c9
A replay of the conference call and webcast will be available for one year beginning on August 10, 2022, at 11:00 a.m. EDT using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Sr. Director-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2023-earnings-release-available-on-investor-relations-website-301602928.html
SOURCE Haemonetics Corporation
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member